Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon. Fluxion believes that the lawsuit is without merit and that Fluxion’s innovative IonFlux™ automated patch clamp system does not infringe the asserted patents. Fluxion intends to defend this lawsuit vigorously.

“Fluxion has invested considerable time and resources to develop its own intellectual property position for cell-based screening systems, and we respect the intellectual property rights of others. Cellectricon’s claim of patent infringement is a baseless attempt to block Fluxion’s penetration and growth in the ion channel screening market.”

Jeff Jensen, Chief Executive Officer of Fluxion, said in response to the lawsuit: "Fluxion has invested considerable time and resources to develop its own intellectual property position for cell-based screening systems, and we respect the intellectual property rights of others. Cellectricon’s claim of patent infringement is a baseless attempt to block Fluxion’s penetration and growth in the ion channel screening market.”

SOURCE Fluxion Biosciences

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fluxion Biosciences. (2010, February 03). Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit. News-Medical. Retrieved on April 13, 2024 from https://www.news-medical.net/news/20100203/Fluxion-Biosciences-to-defend-against-alleged-automated-patch-clamp-system-patent-infringement-lawsuit.aspx.

  • MLA

    Fluxion Biosciences. "Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit". News-Medical. 13 April 2024. <https://www.news-medical.net/news/20100203/Fluxion-Biosciences-to-defend-against-alleged-automated-patch-clamp-system-patent-infringement-lawsuit.aspx>.

  • Chicago

    Fluxion Biosciences. "Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit". News-Medical. https://www.news-medical.net/news/20100203/Fluxion-Biosciences-to-defend-against-alleged-automated-patch-clamp-system-patent-infringement-lawsuit.aspx. (accessed April 13, 2024).

  • Harvard

    Fluxion Biosciences. 2010. Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit. News-Medical, viewed 13 April 2024, https://www.news-medical.net/news/20100203/Fluxion-Biosciences-to-defend-against-alleged-automated-patch-clamp-system-patent-infringement-lawsuit.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluxion Biosciences announces launch of Discovery Services business